Off-Label Promotion Prosecutors Watch Second-Generation Indications
Executive Summary
Federal prosecutors weighing action against off-label drug promotions will look carefully at the indications manufacturers seek for second-generation products as a marker for whether to pursue a case, Boston Assistant U.S. Attorney Michael Loucks told an American Conference Institute forum Oct. 21 in New York City